Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001–2013
Highlights • We analyse the trend of invasive pneumococcal disease in the 13-valent vaccine era. • The incidence of cases has declined notably in children and moderately in adults. • The incidence of cases due to vaccine serotypes decreased 81% in children <5 years. • The moderate decline in adul...
Saved in:
Published in | Vaccine Vol. 32; no. 22; pp. 2553 - 2562 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
07.05.2014
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Highlights • We analyse the trend of invasive pneumococcal disease in the 13-valent vaccine era. • The incidence of cases has declined notably in children and moderately in adults. • The incidence of cases due to vaccine serotypes decreased 81% in children <5 years. • The moderate decline in adults suggests the indirect effect of vaccination. • No changes indicating serotype replacement have been detected. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2014.03.054 |